华恒生物 (688639.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(华恒生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度每股收益(元) 1.001.001.001.001.001.001.00
 单季度销售毛利率(%) 40.0045.0039.0037.0041.0038.0039.00
 单季度销售净利率(%) 25.0024.0020.0024.0025.0021.0020.00
 单季度净资产收益率ROE(%) 8.007.005.007.007.006.005.00
 单季度总资产净利率ROA(%) 5.005.004.005.005.005.004.00
单季度财务摘要:
 单季度营业总收入(元) 514,272,655.00449,633,854.00400,254,754.00434,874,964.00354,868,241.00358,501,788.00270,406,891.00
 单季度营业总成本(元) 377,595,007.00318,257,776.00310,953,639.00338,208,799.00265,549,676.00278,312,035.00210,217,632.00
 单季度营业收入(元) 514,272,655.00449,633,854.00400,254,754.00434,874,964.00354,868,241.00358,501,788.00270,406,891.00
 单季度营业利润(元) 142,067,898.00134,665,601.0091,998,601.0096,718,704.0093,743,621.0086,935,023.0064,647,308.00
 单季度利润总额(元) 141,533,620.00129,397,586.0091,749,531.0096,662,370.0097,756,273.0083,997,061.0064,567,911.00
 单季度净利润(元) 128,280,438.00109,930,361.0081,188,337.00102,354,195.0087,998,609.0073,762,395.0055,226,359.00
 单季度归属母公司股东的净利润(元) 128,712,552.00110,038,359.0081,198,285.00102,995,428.0088,045,268.0073,762,395.0055,226,359.00
 单季度经营活动产生的现金流量(元) 110,472,738.00167,720,105.0091,795,731.00109,957,755.0081,700,939.0097,471,365.0068,295,013.00
 单季度投资活动产生的现金流量(元) -457,995,244.00-250,812,906.00-66,009,055.00-342,686,795.00112,259,035.00-50,116,575.00-61,460,609.00
 单季度筹资活动产生的现金流量(元) 293,123,750.0025,913,608.00113,947,654.0028,953,388.00-59,723,749.0021,166,236.0016,064,102.00
 单季度现金及现金等价物净增加(元) -52,460,547.00-53,077,312.00139,683,066.00-204,364,515.00138,221,426.0069,946,231.0023,322,972.00

前瞻产业研究院